The "Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The global sinus dilation devices market is anticipated to reach USD 3.8 Billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 6.6%
The growth of the market is primarily driven by the factors such as growing extensiveness of chronic sinusitis and rising inclination of minimally invasive surgeries such as balloon sinuplasty.
The Sinus stents/implants is projected to grow at highest CAGR of 8.2% from 2022 to 2027
Based on the product, the sinus dilation devices market is classified into Balloon sinus dilation devices, Endoscopes (Sinuscopes, Rhinoscopes), Sinus stents/implants, and Handheld instruments. The growth of this market is majorly driven by the factors such as Advantages of balloon dilation procedures compared to traditional endoscopic sinus surgeries and Elevated regularity in chronic sinusitis.
Asia Pacific is estimated to register the highest CAGR during the forecast period
In this report, the sinus dilation devices market is branched into four significant regional segments such as, North America, Europe, Asia Pacific, and the Rest of the World (RoW).
The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising geriatric population, increasing per capita income and presence of low cost treatments.
Competitive landscape
Prominent players in the sinus dilation devices market include Acclarent, Inc. (a subsidiary of Johnson & Johnson) (US), Olympus Corporation (Japan), F. Entellus Medical Inc. (a subsidiary of Stryker) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT, Inc. (US), SinuSys Corporation (US), InnAccel Pvt. Ltd (India), Meril Life Sciences Pvt. Ltd. (India), and Optim LLC (US).
Premium Insights
Market Dynamics
Drivers
Restraints
Opportunities
Challenges
Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/mq62wx
View source version on businesswire.com: https://www.businesswire.com/news/home/20221202005255/en/
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900